重度酒精相关性肝炎患者被拒绝早期肝移植后的多中心结局研究
这项多中心回顾性研究在5个ACCELERATE-AH中心随机抽取被评估后拒绝早期肝移植的酒精相关性肝炎患者,所有患者MELD>20且戒酒<6个月。145例患者中56%因心理社会原因被拒绝,1年生存概率46%,1年再代偿概率仅10.0%。MELD-Na升高和年龄与早期死亡相关,仅有酒精康复失败史与晚期死亡相关。
要点
- 被拒绝早期肝移植的重度酒精相关性肝炎患者1年生存概率仅46%。
- 1年再代偿概率低至10.0%,因临床改善被拒绝者1年再代偿概率为28.0%。
- MELD-Na升高和年龄与早期死亡相关,酒精康复失败史与晚期死亡相关。
核心结论
- 重度酒精相关性肝炎患者被拒绝肝移植后再代偿不常见,MELD-Na升高和年龄与短期死亡相关,仅有酒精康复失败史与长期死亡相关。
- 生存与肝脏再代偿之间的区别值得进一步关注。
研究设计与样本
- 回顾性研究,纳入5个ACCELERATE-AH中心随机抽取的曾被评估并拒绝肝移植的酒精相关性肝炎患者。
- 所有患者MELD>20且戒酒时间<6个月,共145例,61%为男性。
- 采用多水平混合效应线性回归计算再代偿概率,多变量Cox回归进行死亡分析。
主要发现
- 中位戒酒时间和MELD-Na分别为33天(四分位距13-70)和31(四分位距26-36),56%因心理社会原因被拒绝。
- 30天、90天、6个月和1年生存概率分别为76%(95%CI 68%-82%)、59%(95%CI 50%-66%)、49%(95%CI 40%-57%)和46%(95%CI 37%-55%)。
- 1年再代偿概率低至10.0%(95%CI 4.5%-15.4%);因临床改善被拒绝者1年再代偿概率为28.0%(95%CI 5.7%-50.3%)。
- 存活者30天、90天和1年中位MELD-Na分别为29(四分位距22-38)、19(四分位距14-29)和11(四分位距7-17)。
- MELD-Na升高(校正HR 1.13,p<0.001)和年龄(校正HR 1.03,p<0.001)与早期(≤90天)死亡相关,仅有酒精康复失败史(校正HR 1.76,p=0.02)与晚期死亡相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early liver transplantation for alcohol-associated hepatitis is controversial in part because patients may recover, and obviate the need for liver transplantation. METHODS: In this retrospective study among 5 ACCELERATE-AH sites, we randomly sampled patients evaluated and then declined for liver transplantation for alcohol-associated hepatitis. All had Model of End-Stage Liver Disease (MELD) >20 and <6 months of abstinence. Recompensation was defined as MELD <15 without variceal bleeding, ascites, or overt HE requiring treatment. Multilevel mixed effects linear regression was used to calculate probabilities of recompensation; multivariable Cox regression was used for mortality analyses. RESULTS: Among 145 patients [61% men; median abstinence time and MELD-Na was 33 days (interquartile range: 13-70) and 31 (interquartile range: 26-36), respectively], 56% were declined for psychosocial reasons. Probability of 30-day, 90-day, 6-month, and 1-year survival were 76% (95% CI, 68%-82%), 59% (95% CI, 50%-66%), 49% (95% CI, 40%-57%), and 46% (95% CI, 37%-55%), respectively. Probability of 1-year recompensation was low at 10.0% (95% CI, 4.5%-15.4%). Among patients declined because of clinical improvement, 1-year probability of recompensation was 28.0% (95% CI, 5.7%-50.3%). Among survivors, median MELD-Na at 30 days, 90 days, and 1-year were 29 (interquartile range: 22-38), 19 (interquartile range : 14-29), and 11 (interquartile range : 7-17). Increased MELD-Na (adjusted HR: 1.13, p <0.001) and age (adjusted HR: 1.03, p <0.001) were associated with early (≤90 d) death, and only history of failed alcohol rehabilitation (adjusted HR: 1.76, p =0.02) was associated with late death. CONCLUSIONS: Liver recompensation is infrequent among severe alcohol-associated hepatitis patients declined for liver transplantation. Higher MELD-Na and age were associated with short-term mortality, whereas only history of failed alcohol rehabilitation was associated with long-term mortality. The distinction between survival and liver recompensation merits further attention.
引用
- Hsu CC, Dodge JL, Weinberg E, et al. Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis. Hepatology. 2023. PMID: 36651183. doi:10.1097/HEP.0000000000000267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。